|
平成25年の東京都保菌者検索事業実施結果が確定いたしましたので、下記の通りお知らせします。
食品監視課食中毒調査係
1 腸管出血性大腸菌の発生状況累計グラフ
（1）散発患者発生動向調査
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
2 |
1 |
3 |
9 |
2 |
2 |
3 |
4 |
| O157VT1,2 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
1 |
0 |
1 |
2 |
9 |
5 |
3 |
| その他 |
0 |
0 |
0 |
0 |
1 |
2 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
3 |
1 |
2 |
0 |
| 累計 |
0 |
1 |
1 |
1 |
2 |
5 |
6 |
7 |
7 |
8 |
11 |
13 |
16 |
26 |
33 |
45 |
55 |
62 |
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| O157VT1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
6 |
3 |
3 |
0 |
3 |
1 |
3 |
4 |
1 |
2 |
5 |
1 |
3 |
3 |
0 |
0 |
0 |
0 |
| O157VT1,2 |
7 |
15 |
17
|
9 |
13 |
7 |
7 |
7 |
3 |
3 |
7 |
2 |
1 |
1 |
2 |
1 |
1 |
0 |
| その他 |
3 |
4 |
4 |
4 |
6 |
4 |
1 |
1 |
1 |
1 |
1 |
3 |
0 |
3 |
1 |
0 |
0 |
0 |
| 累計 |
78 |
102 |
124 |
137 |
160 |
172 |
183 |
195 |
200 |
206 |
219 |
225 |
230 |
237 |
240 |
241 |
242 |
242 |
（２）無症状病原体保有者調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
| O157VT1,2 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
| その他 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
| 累計 |
0 |
0 |
0 |
1 |
1 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
3 |
6 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
2 |
1 |
1 |
0 |
1 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT1,2 |
1 |
1 |
0 |
1 |
2 |
0 |
1 |
2 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 累計 |
9 |
11 |
13 |
14 |
18 |
19 |
20 |
23 |
25 |
25 |
25 |
25 |
26 |
26 |
26 |
26 |
26 |
26 |
2 サルモネラの発生状況累計グラフ
（1）散発患者発生動向調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
| O7 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O9 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
2 |
1 |
0 |
0 |
0 |
| その他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
| 累計 |
0 |
0 |
0 |
2 |
2 |
2 |
2 |
2 |
4 |
4 |
4 |
4 |
6 |
8 |
9 |
11 |
11 |
11 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
| O7 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
| O9 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
| その他 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
| 累計 |
12 |
13 |
13 |
13 |
13 |
15 |
16 |
18 |
19 |
19 |
19 |
19 |
20 |
22 |
23 |
24 |
25 |
25 |
（２）無症状病原体保有者調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
1 |
2 |
0 |
1 |
3 |
0 |
| O7 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
| O9 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
1 |
2 |
| 累計 |
1 |
1 |
1 |
1 |
2 |
2 |
2 |
3 |
4 |
4 |
4 |
4 |
5 |
7 |
9 |
12 |
17 |
19 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
0 |
0 |
3 |
1 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
| O7 |
1 |
0 |
0 |
1 |
2 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
6 |
1 |
1 |
1 |
1 |
0 |
1 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
| 累計 |
26 |
27 |
28 |
33 |
37 |
37 |
39 |
41 |
43 |
45 |
46 |
46 |
46 |
47 |
48 |
48 |
49 |
49 |
|
